Accordingly, we found divergent expression of PRSS3-SVs toward bipolarity following clinical progression from downregulation in early HCC to upregulation in advanced cancer, unveiling the molecular basis of PRSS3 in tissue-selective expression of its splice transcripts in HCC. The gene discussed is PRSS3; the disease is cancer.